Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.

Carolin C HackNicolai MaassBahriye AktasSherko KümmelChristoph ThomssenChristopher WolfHans-Christian KolbergCosima BruckerWolfgang JanniPeter DallAndreas SchneeweissFrederik MarmeMatthias RuebnerAnna-Katharin TheuserNadine M HofmannSybille BöhmKatrin AlmstedtSara KellnerNaiba NabievaPaul GassMarc W SütterlinHans-Joachim LückSabine SchmatlochMatthias KalderChristoph UleerIngolf Juhasz-BössVolker HanfChristian JackischVolkmar MüllerBrigitte RackErik BellevilleDiethelm WallwienerAchim RodyClaudia RauhChristian M BayerSabrina UhrigChloë GoossensHanna HuebnerSara Y BruckerLothar HäberleTanja N FehmAlexander HeinPeter A Fasching

Published in: Geburtshilfe und Frauenheilkunde (2024)

[This corrects the article DOI: 10.1055/a-2238-3153.].

Keyphrases

early breast cancer
end stage renal disease
ejection fraction
healthcare
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
quality improvement
type diabetes
metabolic syndrome
patient reported outcomes
bone marrow
chronic pain
health insurance